All Stories

  1. Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
  2. Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition
  3. Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
  4. Deletion of Jazf1 gene causes early growth retardation and insulin resistance in mice
  5. Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis
  6. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
  7. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
  8. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action
  9. Mechanisms of Insulin Action and Insulin Resistance
  10. PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling
  11. The circulating metabolome of human starvation
  12. Lacteal junction zippering protects against diet-induced obesity
  13. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
  14. Deciphering the Role of Lipid Droplets in Cardiovascular Disease
  15. Loss of Nucleobindin-2 Causes Insulin Resistance in Obesity without Impacting Satiety or Adiposity
  16. Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer
  17. Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
  18. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia
  19. The link between insulin and fatty liver
  20. Effect of a Controlled-Release Mitochondrial Protonophore (CRMP) on Healthspan and Lifespan in Mice
  21. Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
  22. The Role of Leptin in Maintaining Plasma Glucose During Starvation
  23. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents
  24. In vivo studies on the mechanism of methylene cyclopropyl acetic acid and methylene cyclopropyl glycine-induced hypoglycemia
  25. Publisher Correction: Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
  26. Skeletal Muscle–Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance
  27. Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation
  28. Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
  29. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
  30. Mechanism by which arylamine N -acetyltransferase 1 ablation causes insulin resistance in mice
  31. Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling
  32. Retinol saturase modulates lipid metabolism and the production of reactive oxygen species
  33. Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms
  34. Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
  35. Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport
  36. Regulation of hepatic glucose metabolism in health and disease
  37. Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
  38. The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism
  39. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
  40. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
  41. Mitochondrial-Targeted Catalase Protects Against High-Fat Diet–Induced Muscle Insulin Resistance by Decreasing Intramuscular Lipid Accumulation
  42. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice
  43. Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
  44. A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo
  45. Adipocyte JAK2 mediates growth hormone–induced hepatic insulin resistance
  46. Mechanism for leptin’s acute insulin-independent effect to reverse diabetic ketoacidosis
  47. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism
  48. Insulin Resistance in Type 2 Diabetes
  49. Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver
  50. Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism
  51. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
  52. CD301b + Mononuclear Phagocytes Maintain Positive Energy Balance through Secretion of Resistin-like Molecule Alpha
  53. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
  54. Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents
  55. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice
  56. Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by 13 C Magnetic Resonance Spectroscopy
  57. Hypophosphatemia promotes lower rates of muscle ATP synthesis
  58. XBP1s Is an Anti-lipogenic Protein
  59. Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
  60. Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism
  61. Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance
  62. Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism
  63. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis
  64. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice
  65. AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia
  66. 17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization
  67. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
  68. Metabolic Syndrome
  69. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents
  70. Second-generation antisense oligonucleotides against  -catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance
  71. Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)
  72. Macrophage-specificde NovoSynthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity
  73. Correction for Petersen et al., Effect of aging on muscle mitochondrial substrate utilization in humans
  74. Mechanism by which caloric restriction improves insulin sensitivity in sedentary obese adults
  75. Effect of aging on muscle mitochondrial substrate utilization in humans
  76. Type 2 diabetes mellitus
  77. Short-term food restriction followed by controlled refeeding promotes gorging behavior, enhances fat deposition, and diminishes insulin sensitivity in mice
  78. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
  79. Pathogenesis of type 2 diabetes mellitus
  80. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
  81. Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
  82. Response to Burgess
  83. Reply to Constantin-Teodosiu et al.: Mice with genetic PDH activation are not protected from high-fat diet–induced muscle insulin resistance
  84. Neuronal UCP1 expression suggests a mechanism for local thermogenesis during hibernation
  85. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
  86. Acetylation of TUG Protein Promotes the Accumulation of GLUT4 Glucose Transporters in an Insulin-responsive Intracellular Compartment
  87. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
  88. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  89. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  90. Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II
  91. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
  92. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells
  93. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance
  94. Hepatic Mitogen-Activated Protein Kinase Phosphatase 1 Selectively Regulates Glucose Metabolism and Energy Homeostasis
  95. Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
  96. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  97. Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
  98. PKCλ Haploinsufficiency Prevents Diabetes by a Mechanism Involving Alterations in Hepatic Enzymes
  99. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
  100. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
  101. Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes
  102. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
  103. Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression
  104. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
  105. Ceramide-Activated Phosphatase Mediates Fatty Acid–Induced Endothelial VEGF Resistance and Impaired Angiogenesis
  106. Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice
  107. Early Life Exposure to Maternal Insulin Resistance Has Persistent Effects on Hepatic NAFLD in Juvenile Nonhuman Primates
  108. Ostα−/− mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity
  109. A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis
  110. Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
  111. Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
  112. Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch
  113. Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy
  114. Treating fatty liver and insulin resistance
  115. The Mammalian INDY Homolog Is Induced by CREB in a Rat Model of Type 2 Diabetes
  116. Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
  117. PP2A inhibition results in hepatic insulin resistance despite Akt2 activation
  118. A β-Peptide Agonist of the GLP-1 Receptor, a Class B GPCR
  119. Impairment of insulin-stimulated glucose transport and ERK activation by adipocyte-specific knockout of PKC-λ produces a phenotype characterized by diminished adiposity and enhanced insulin suppression of hepatic gluconeogenesis
  120. Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
  121. Lipid-induced hepatic insulin resistance
  122. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo
  123. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
  124. Enhanced Fasting Glucose Turnover in Mice with Disrupted Action of TUG Protein in Skeletal Muscle
  125. Increased Brain Lactate Concentrations Without Increased Lactate Oxidation During Hypoglycemia in Type 1 Diabetic Individuals
  126. cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis
  127. Fish Oil Selectively Improves Heart Function in a Mouse Model of Lipid-induced Cardiomyopathy
  128. Role of caspase-1 in regulation of triglyceride metabolism
  129. Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance
  130. Mechanisms Underlying the Onset of Oral Lipid-Induced Skeletal Muscle Insulin Resistance in Humans
  131. Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
  132. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats
  133. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
  134. The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
  135. Decreased Transcription of ChREBP- /  Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes: Associations With Insulin Resistance and Hyperglycemia
  136. The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis
  137. 31P-Magnetization Transfer Magnetic Resonance Spectroscopy Measurements of In Vivo Metabolism
  138. Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism
  139. Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism
  140. Development of insulin resistance in mice lacking PGC-1α in adipose tissues
  141. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
  142. Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
  143. Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes
  144. Mechanisms for Insulin Resistance: Common Threads and Missing Links
  145. Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes
  146. Thyroid Hormone Receptor-α Gene Knockout Mice Are Protected from Diet-Induced Hepatic Insulin Resistance
  147. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
  148. Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure
  149. A guide to analysis of mouse energy metabolism
  150. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats
  151. Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice
  152. SirT1 Regulates Adipose Tissue Inflammation
  153. Dissociation of the Glucose and Lipid Regulatory Functions of FoxO1 by Targeted Knockin of Acetylation-Defective Alleles in Mice
  154. Impact of CD1d Deficiency on Metabolism
  155. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  156. Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
  157. Indy knockdown in mice mimics elements of dietary restriction
  158. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance
  159. Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism
  160. Deletion of the Mammalian INDY Homolog Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in Mice
  161. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals
  162. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
  163. GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
  164. Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype
  165. Magnetic Resonance Spectroscopy Studies of Human Metabolism
  166. Lysophosphatidic Acid Activates Peroxisome Proliferator Activated Receptor-γ in CHO Cells That Over-Express Glycerol 3-Phosphate Acyltransferase-1
  167. FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
  168. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
  169. Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance
  170. Characterization of the Hyperphagic Response to Dietary Fat in the MC4R Knockout Mouse
  171. SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
  172. Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
  173. Diabetes in Mice With Selective Impairment of Insulin Action in Glut4-Expressing Tissues
  174. Mouse Cardiac Acyl Coenzyme A Synthetase 1 Deficiency Impairs Fatty Acid Oxidation and Induces Cardiac Hypertrophy
  175. Regulation of Hepatic Glucose Uptake
  176. Sirtuin-1 regulation of mammalian metabolism
  177. Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance
  178. Targeted Expression of Catalase to Mitochondria Prevents Age-Associated Reductions in Mitochondrial Function and Insulin Resistance
  179. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
  180. The Contribution of Blood Lactate to Brain Energy Metabolism in Humans Measured by Dynamic 13C Nuclear Magnetic Resonance Spectroscopy
  181. PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
  182. Downregulation ofADIPOQandPPARγ2Gene Expression in Subcutaneous Adipose Tissue of Obese Adolescents With Hepatic Steatosis
  183. Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways
  184. Cellularity and Adipogenic Profile of the Abdominal Subcutaneous Adipose Tissue From Obese Adolescents: Association With Insulin Resistance and Hepatic Steatosis
  185. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents
  186. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
  187. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
  188. The Role of Muscle Insulin Resistance in the Pathogenesis of Atherogenic Dyslipidemia and Nonalcoholic Fatty Liver Disease Associated with the Metabolic Syndrome
  189. Regulation of mitochondrial biogenesis
  190. Lipid-induced insulin resistance: unravelling the mechanism
  191. Uncoupling Protein-2 Decreases the Lipogenic Actions of Ghrelin
  192. Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
  193. Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia
  194. Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
  195. Diacylglycerol-mediated insulin resistance
  196. Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
  197. Deletion of the  -Arrestin Protein Txnip in Mice Promotes Adiposity and Adipogenesis While Preserving Insulin Sensitivity
  198. Glycerol-3-Phosphate Acyltransferase 1 Deficiency in ob/ob Mice Diminishes Hepatic Steatosis but Does Not Protect Against Insulin Resistance or Obesity
  199. PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
  200. Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein
  201. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
  202. Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
  203. Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance Spectroscopy
  204. Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1
  205. Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition
  206. Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion
  207. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
  208. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats
  209. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans
  210. Mitochondrial Dysfunction Contributes to Impaired Insulin Secretion in INS-1 Cells with Dominant-negative Mutations of HNF-1α and in HNF-1α-deficient Islets
  211. Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-  Coactivator-1  Expression
  212. STAT3 inhibition of gluconeogenesis is downregulated by SirT1
  213. The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator-1 β in the Pathogenesis of Fructose-Induced Insulin Resistance
  214. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
  215. Adipose Overexpression of Desnutrin Promotes Fatty Acid Use and Attenuates Diet-Induced Obesity
  216. Increased Energy Expenditure and Insulin Sensitivity in the High Bone Mass ΔFosB Transgenic Mice
  217. METABOLISM
  218. Chapter 21 Assessment of In Vivo Mitochondrial Metabolism by Magnetic Resonance Spectroscopy
  219. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism
  220. N-acylphosphatidylethanolamine, a Gut- Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake
  221. Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals
  222. Resistance to High-Fat Diet-Induced Obesity but Exacerbated Insulin Resistance in Mice Overexpressing Preadipocyte Factor-1 (Pref-1): A New Model of Partial Lipodystrophy
  223. UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
  224. Muscle-Specific IRS-1 Ser->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle
  225. Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice
  226. Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight
  227. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL
  228. A Prevalent Variant in PPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice
  229. Dual role of proapoptotic BAD in insulin secretion and beta cell survival
  230. Regulation of hypothalamic malonyl-CoA by central glucose and leptin
  231. Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalk
  232. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance
  233. Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity
  234. Obesity-associated improvements in metabolic profile through expansion of adipose tissue
  235. Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes
  236. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
  237. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance
  238. Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents
  239. Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but NotDGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance
  240. Synaptic Glutamate Release by Ventromedial Hypothalamic Neurons Is Part of the Neurocircuitry that Prevents Hypoglycemia
  241. Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance
  242. Mitochondrial GTP Regulates Glucose-Stimulated Insulin Secretion
  243. Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance
  244. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo
  245. Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
  246. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients
  247. Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis
  248. n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator-Activated Receptor- -Dependent Manner
  249. Measurements of the anaplerotic rate in the human cerebral cortex using13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose
  250. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals
  251. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance
  252. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
  253. Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
  254. Cytosolic and Mitochondrial Malic Enzyme Isoforms Differentially Control Insulin Secretion
  255. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle
  256. Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice
  257. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
  258. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity
  259. Regulation of Metabolic Responses by Adipocyte/ Macrophage Fatty Acid-Binding Proteins in Leptin-Deficient Mice
  260. Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action
  261. The role of AMP-activated protein kinase in mitochondrial biogenesis
  262. Introduction
  263. Etiology of Insulin Resistance
  264. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice
  265. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis
  266. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
  267. Fish Oil Regulates Adiponectin Secretion by a Peroxisome Proliferator-Activated Receptor- -Dependent Mechanism in Mice
  268. Increased Brain Monocarboxylic Acid Transport and Utilization in Type 1 Diabetes
  269. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2
  270. New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance Spectroscopy
  271. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
  272. Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
  273. The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes
  274. MRS Studies of the Role of the Muscle Glycogen Synthesis Pathway in the Pathophysiology of Type 2 Diabetes
  275. Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents
  276. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice
  277. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart
  278. The “Obese Insulin-Sensitive” Adolescent: Importance of Adiponectin and Lipid Partitioning
  279. Adipocyte-Specific Overexpression of FOXC2 Prevents Diet-Induced Increases in Intramuscular Fatty Acyl CoA and Insulin Resistance
  280. Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential in Liver for the Metabolism of Excess Acyl-CoAs
  281. Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
  282. Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes
  283. Mitochondrial Dysfunction and Type 2 Diabetes
  284. Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes
  285. A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA
  286. Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
  287. PKC-θ knockout mice are protected from fat-induced insulin resistance
  288. 13C NMR Isotopomer Analysis of Anaplerotic Pathways in INS-1 Cells
  289. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  290. Unraveling the Cellular Mechanism of Insulin Resistance in Humans: New Insights from Magnetic Resonance Spectroscopy
  291. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
  292. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation
  293. Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action
  294. Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
  295. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
  296. Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
  297. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance
  298. Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-  in fasting mice
  299. Effects of depletion exercise and light training on muscle glycogen supercompensation in men
  300. Cellular mechanism of insulin resistance: potential links with inflammation
  301. Genetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
  302. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning
  303. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise
  304. Insulin Resistance in Tetracycline-Repressible Munc18c Transgenic Mice
  305. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry
  306. Differential Effects of Rosiglitazone on Skeletal Muscle and Liver Insulin Resistance in A-ZIP/F-1 Fatless Mice
  307. Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
  308. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
  309. Low Adiponectin Levels in Adolescent Obesity: A Marker of Increased Intramyocellular Lipid Accumulation
  310. Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke
  311. Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia
  312. Skeletal muscle lipid metabolism with obesity
  313. Local Lactate Perfusion of the Ventromedial Hypothalamus Suppresses Hypoglycemic Counterregulation
  314. A comparison of 13C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-13C]glucose
  315. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation
  316. Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle
  317. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat
  318. Effect of Weight Loss on Insulin Sensitivity and Intramuscular Long-Chain Fatty Acyl-CoAs in Morbidly Obese Subjects
  319. Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats
  320. Nonalcoholic Fatty Liver Disease
  321. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
  322. Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C lambda /zeta but Not on Glycogen Synthase Kinase-3
  323. Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity
  324. [2,4-13C2]-β-Hydroxybutyrate Metabolism in Human Brain
  325. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction
  326. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
  327. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
  328. Assessment of Skeletal Muscle Triglyceride Content by 1H Nuclear Magnetic Resonance Spectroscopy in Lean and Obese Adolescents: Relationships to Insulin Sensitivity, Total Body Fat, and Central Adiposity
  329. Astroglial Contribution to Brain Energy Metabolism in Humans Revealed by13C Nuclear Magnetic Resonance Spectroscopy: Elucidation of the Dominant Pathway for Neurotransmitter Glutamate Repletion and Measurement of Astrocytic Oxidative Metabolism
  330. The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes
  331. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content
  332. Inclusion of Low Amounts of Fructose With an Intraduodenal Glucose Load Markedly Reduces Postprandial Hyperglycemia and Hyperinsulinemia in the Conscious Dog
  333. Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia
  334. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
  335. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle
  336. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
  337. Prevention of fat-induced insulin resistance by salicylate
  338. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
  339. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
  340. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBbeta )
  341. Stimulating Effects of Low-Dose Fructose on Insulin-Stimulated Hepatic Glycogen Synthesis in Humans
  342. Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes
  343. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance
  344. Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans
  345. Effect of 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside Infusion on In Vivo Glucose and Lipid Metabolism in Lean and Obese Zucker Rats
  346. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance
  347. In VivoEffects of Uncoupling Protein-3 Gene Disruption on Mitochondrial Energy Metabolism
  348. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
  349. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways
  350. Lipid-dependent control of hepatic glycogen stores in healthy humans
  351. Nuclear Magnetic Resonance Studies of Hepatic Glucose Metabolism in Humans
  352. Mechanism by which metformin reduces glucose production in type 2 diabetes
  353. 13C/31P NMR Assessment of Mitochondrial Energy Coupling in Skeletal Muscle of Awake Fed and Fasted Rats
  354. Contrasting Effects of IRS-1VersusIRS-2 Gene Disruption on Carbohydrate and Lipid Metabolismin Vivo
  355. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
  356. Cellular mechanisms of insulin resistance
  357. Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction
  358. Regulation of myocardial [13C]glucose metabolism in conscious rats
  359. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
  360. Effects of Caffeine on Muscle Glycogen Utilization and the Neuroendocrine Axis during Exercise
  361. Assessment of mitochondrial energy coupling in vivo by 13 C/ 31 P NMR
  362. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans
  363. Mechanism of troglitazone action in type 2 diabetes
  364. Mechanism of muscle glycogen autoregulation in humans
  365. Transgenic mice overexpressing GLUT-1 protein in muscle exhibit increased muscle glycogenesis after exercise
  366. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
  367. Persistent Changes in Myocardial Glucose Metabolism In Vivo During Reperfusion of a Limited-Duration Coronary Occlusion
  368. Glycogen loading alters muscle glycogen resynthesis after exercise
  369. Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13C and 1H Nuclear Magnetic Resonance Spectroscopy Study
  370. Spectroscopic imaging of glutamate C4 turnover in human brain
  371. Intense exercise stimulates albumin synthesis in the upright posture
  372. Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes
  373. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13 C NMR
  374. Cellular mechanisms of insulin resistance in humans
  375. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
  376. Regulation of myocardial glucose uptake and transport during ischemia and energetic stress
  377. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats
  378. APPLICATIONS OF NMR SPECTROSCOPY TO STUDY MUSCLE GLYCOGEN METABOLISM IN MAN
  379. Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity
  380. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study
  381. NMR Studies on the Mechanism of Insulin Resistance
  382. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study
  383. Additive Effects of Hyperinsulinemia and Ischemia on Myocardial GLUT1 and GLUT4 Translocation In Vivo
  384. Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
  385. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
  386. 13C/31P NMR studies on the mechanism of insulin resistance in obesity
  387. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
  388. Disruption of IRS-2 causes type 2 diabetes in mice
  389. Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus
  390. Regulation of exogenous and endogenous glucose metabolism by insulin and acetoacetate in the isolated working rat heart. A three tracer study of glycolysis, glycogen metabolism, and glucose oxidation.
  391. In vivo NMR investigation of intramuscular glucose metabolism in conscious rats
  392. Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study
  393. Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.
  394. 13C and31P NMR Studies on the Effects of Increased Plasma Free Fatty Acids on Intramuscular Glucose Metabolism in the Awake Rat
  395. Low-Flow Ischemia Leads to Translocation of Canine Heart GLUT-4 and GLUT-1 Glucose Transporters to the Sarcolemma In Vivo
  396. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.
  397. The Effect of Leptin Is Enhanced by Microinjection Into the Ventromedial Hypothalamus
  398. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria.
  399. Time course of the defective α-cell response to hypoglycemia in diabetic BB rats
  400. Increased Glucose Transport–Phosphorylation and Muscle Glycogen Synthesis after Exercise Training in Insulin-Resistant Subjects
  401. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.
  402. Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.
  403. Noninvasive assessment of hepatic triglyceride content in humans with13C nuclear magnetic resonance spectroscopy
  404. Mechanism of free fatty acid-induced insulin resistance in humans.
  405. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.
  406. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
  407. Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period
  408. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.
  409. Mass and Positional Isotopomer Analysis of Glucose Metabolism in Periportal and Pericentral Hepatocytes
  410. Triiodothyronine treatment increases substrate cycling between pyruvate carboxylase and malic enzyme in perfused rat liver
  411. Central adiposity and its metabolic correlates in obese adolescent girls
  412. Islet Phosphoinositide Hydrolysis and Insulin Secretory Responses from Prediabetic fA/fA ZDF Rats
  413. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.
  414. Contribution of Hepatic Glycogenolysis to Glucose Production in Humans in Response to a Physiological Increase in Plasma Glucagon Concentration
  415. Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.
  416. Local Ventromedial Hypothalamus Glucopenia Triggers Counterregulatory Hormone Release
  417. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.
  418. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.
  419. Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats
  420. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels
  421. Validation of13C NMR measurements of liver glycogenin vivo
  422. Liver glycogen turnover in fed and fasted humans
  423. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
  424. Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases
  425. In vivo regulation of rat muscle glycogen resynthesis after intense exercise
  426. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.
  427. Temporal changes in insulin resistance and secretion in 24-h-fasted conscious pregnant rats
  428. Inhibitory Effect of Pregnancy on Counterregulatory Hormone Responses to Hypoglycemia in Awake Rat
  429. Effect of hepatic nerves on disposition of an intraduodenal glucose load
  430. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects
  431. Comparative Effects of Monomethylsuccinate and Glucose on Insulin Secretion from Perifused Rat Islets
  432. Enhancement of the gluconeogenic flux of hepatic glycogen repletion by a phenacyl imidazolium compound in vivo
  433. Cerebral Lactate Turnover after Electroshock: In vivo Measurements by 1H/13C Magnetic Resonance Spectroscopy
  434. Immunocytochemical localization of alpha-protein kinase C in rat pancreatic beta-cells during glucose-induced insulin secretion
  435. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.
  436. Pathways of glycogen repletion
  437. Detection and assignment of the glucose signal in1h nmr difference spectra of the human brain
  438. Validation of13c nmr measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples
  439. Simultaneous Insulinlike Growth Factor I and Insulin Resistance in Obese Zucker Rats
  440. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.
  441. Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy.
  442. Hypopituitarism associated with a hypothalamic CMV infection in a patient with AIDS
  443. N.m.r. studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjects
  444. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR
  445. Localized proton NMR observation of [3-13C] lactate in stroke after [1-13C] glucose infusion
  446. The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats
  447. Sources of carbon for hepatic glycogen synthesis in the conscious dog.
  448. Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion
  449. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats
  450. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.
  451. Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans.
  452. Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations
  453. Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy
  454. Chronicin VivoHyperglycemia Impairs Phosphoinositide Hydrolysis and Insulin Release in Isolated Perifused Rat Islets*
  455. Influence of the route of glucose administration on hepatic glycogen repletion
  456. Effect of dietary protein on in vivo insulin action and liver glycogen repletion
  457. Direct observation of glycogen synthesis in human muscle with 13C NMR.
  458. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
  459. Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding
  460. Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat.
  461. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.
  462. Plasma Level of 13,14-Dihydro-15-keto-PGE2 in Patients With Diabetic Ketoacidosis and in Normal Fasting Subjects
  463. Metabolic Response to Three Years of Continuous, Basal Rate Intravenous Insulin Infusion in Type II Diabetic Patients*
  464. Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy.
  465. A 1H NMR technique for observing metabolite signals in the spectrum of perfused liver.
  466. Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.
  467. 23Na and 39K NMR studies of ion transport in human erythrocytes.
  468. Nuclear magnetic resonance spectroscopy in diagnostic and investigative medicine.
  469. Implantable Insulin Infusion Devices
  470. Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog
  471. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog
  472. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog.
  473. Glucose Disposal during Insulinopenia in Somatostatin-Treated Dogs
  474. Insulin Resistance